Lee Jones

Lee Jones

Co-founder, president, and CEO, Rebiotix Inc. 

Description

An innovator with experience both building and leading life sciences companies, Lee Jones co-founded Rebiotix Inc. in 2011 to create the world’s first microbiome-based therapeutic under the company’s Microbiota Restoration Therapy (MRT) drug platform. Fueled by her passion for addressing patient needs, Jones has led her team with deep experience in this new field of medicine. Roseville-based Rebiotix was acquired by Ferring Pharmaceuticals in 2018; Jones continues to drive innovation, including the development of the company’s first biologic drug targeted at recurrent Clostridioides difficile infection (rCDI). Jones serves on the board of Electromed and the advisory boards of Medical Alley Association and University of Minnesota’s Office of Technology Commercialization.